259 related articles for article (PubMed ID: 8455616)
21. 60 YEARS OF POMC: Transcriptional and epigenetic regulation of POMC gene expression.
Drouin J
J Mol Endocrinol; 2016 May; 56(4):T99-T112. PubMed ID: 26792828
[TBL] [Abstract][Full Text] [Related]
22. The Pan basic helix-loop-helix proteins are required for insulin gene expression.
Vierra CA; Nelson C
Mol Endocrinol; 1995 Jan; 9(1):64-71. PubMed ID: 7760851
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the human proopiomelanocortin gene promoter in a small cell lung carcinoma cell line reveals an unusual role for E2F transcription factors.
Picon A; Bertagna X; de Keyzer Y
Oncogene; 1999 Apr; 18(16):2627-33. PubMed ID: 10353606
[TBL] [Abstract][Full Text] [Related]
24. Tissue-specific activity of the pro-opiomelanocortin gene promoter.
Jeannotte L; Trifiro MA; Plante RK; Chamberland M; Drouin J
Mol Cell Biol; 1987 Nov; 7(11):4058-64. PubMed ID: 3431549
[TBL] [Abstract][Full Text] [Related]
25. A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy.
Bousquet C; Ray DW; Melmed S
J Biol Chem; 1997 Apr; 272(16):10551-7. PubMed ID: 9099700
[TBL] [Abstract][Full Text] [Related]
26. Tbx19, a tissue-selective regulator of POMC gene expression.
Liu J; Lin C; Gleiberman A; Ohgi KA; Herman T; Huang HP; Tsai MJ; Rosenfeld MG
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8674-9. PubMed ID: 11447259
[TBL] [Abstract][Full Text] [Related]
27. High glucose activates pituitary proopiomelanocortin gene expression: possible role of free radical-sensitive transcription factors.
Asaba K; Iwasaki Y; Asai M; Yoshida M; Nigawara T; Kambayashi M; Hashimoto K
Diabetes Metab Res Rev; 2007 May; 23(4):317-23. PubMed ID: 16921546
[TBL] [Abstract][Full Text] [Related]
28. Cell-specific pituitary gene expression profiles after treatment with leukemia inhibitory factor reveal novel modulators for proopiomelanocortin expression.
Abbud RA; Kelleher R; Melmed S
Endocrinology; 2004 Feb; 145(2):867-80. PubMed ID: 14576184
[TBL] [Abstract][Full Text] [Related]
29. Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription.
Drouin J; Trifiro MA; Plante RK; Nemer M; Eriksson P; Wrange O
Mol Cell Biol; 1989 Dec; 9(12):5305-14. PubMed ID: 2586521
[TBL] [Abstract][Full Text] [Related]
30. Functional analysis of the human pro-opiomelanocortin promoter in the small cell lung carcinoma cell line DMS-79.
Picon A; Leblond-Francillard M; Raffin-Sanson ML; Lenne F; Bertagna X; de Keyzer Y
J Mol Endocrinol; 1995 Oct; 15(2):187-94. PubMed ID: 8800643
[TBL] [Abstract][Full Text] [Related]
31. The basic helix-loop-helix, leucine zipper transcription factor, USF (upstream stimulatory factor), is a key regulator of SF-1 (steroidogenic factor-1) gene expression in pituitary gonadotrope and steroidogenic cells.
Harris AN; Mellon PL
Mol Endocrinol; 1998 May; 12(5):714-26. PubMed ID: 9605934
[TBL] [Abstract][Full Text] [Related]
32. Basic helix-loop-helix proteins can act at the E-box within the serum response element of the c-fos promoter to influence hormone-induced promoter activation in Sertoli cells.
Chaudhary J; Skinner MK
Mol Endocrinol; 1999 May; 13(5):774-86. PubMed ID: 10319327
[TBL] [Abstract][Full Text] [Related]
33. Synergistic signaling by corticotropin-releasing hormone and leukemia inhibitory factor bridged by phosphorylated 3',5'-cyclic adenosine monophosphate response element binding protein at the Nur response element (NurRE)-signal transducers and activators of transcription (STAT) element of the proopiomelanocortin promoter.
Mynard V; Latchoumanin O; Guignat L; Devin-Leclerc J; Bertagna X; Barré B; Fagart J; Coqueret O; Catelli MG
Mol Endocrinol; 2004 Dec; 18(12):2997-3010. PubMed ID: 15319449
[TBL] [Abstract][Full Text] [Related]
34. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
Bousquet C; Zatelli MC; Melmed S
J Clin Invest; 2000 Dec; 106(11):1417-25. PubMed ID: 11104795
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoid repression of pro-opiomelanocortin gene transcription.
Drouin J; Sun YL; Nemer M
J Steroid Biochem; 1989; 34(1-6):63-9. PubMed ID: 2626052
[TBL] [Abstract][Full Text] [Related]
36. Proopiomelanocortin gene expression and DNA methylation: implications for Cushing's syndrome and beyond.
Newell-Price J
J Endocrinol; 2003 Jun; 177(3):365-72. PubMed ID: 12773116
[TBL] [Abstract][Full Text] [Related]
37. Role of NeuroD1 on the negative regulation of Pomc expression by glucocorticoid.
Parvin R; Saito-Hakoda A; Shimada H; Shimizu K; Noro E; Iwasaki Y; Fujiwara K; Yokoyama A; Sugawara A
PLoS One; 2017; 12(4):e0175435. PubMed ID: 28406939
[TBL] [Abstract][Full Text] [Related]
38. Regulatory elements of the human proopiomelanocortin gene promoter.
Kraus J; Buchfelder M; Höllt V
DNA Cell Biol; 1993; 12(6):527-36. PubMed ID: 8329120
[TBL] [Abstract][Full Text] [Related]
39. A role for Sp and helix-loop-helix transcription factors in the regulation of the human Id4 gene promoter activity.
Pagliuca A; Cannada-Bartoli P; Lania L
J Biol Chem; 1998 Mar; 273(13):7668-74. PubMed ID: 9516472
[TBL] [Abstract][Full Text] [Related]
40. Regulation of human P2X1 promoter activity by beta helix-loop-helix factors in smooth muscle cells.
Dhulipala PD; Lianos EA; Kotlikoff MI
Gene; 2001 May; 269(1-2):167-75. PubMed ID: 11376948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
